Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion type Assertion NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_head.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion description "[Our findings indicate both COX-2-dependent and -independent mechanisms attributable to celecoxib and support its utility in the management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_provenance.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion evidence source_evidence_literature NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_provenance.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion SIO_000772 18089846 NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_provenance.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion wasDerivedFrom befree-2016 NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_provenance.
- NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_assertion wasGeneratedBy ECO_0000203 NP646039.RAfRkeq_CHo6PDhR-XbU7jSqMWLh6u8m9VVTLNMLj6nEY130_provenance.